Literature DB >> 24507315

Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation.

Hitendra S Mahajan1, Sadanand A Gundare2.   

Abstract

The purpose of the present investigation was to prepare microspheres using xyloglucan as the polymer and to evaluate them for pulmonary delivery of Montelucast. Xyloglucan microspheres were prepared using spray-drying technique employing lactose monohydrate as carrier for dry powder inhalation. The formulation of microspheres was optimized using response surface methodology. Multiple response surface simultaneous optimizations using desirability approach were use to find optimal formulation. In vitro characterization of optimized microsphere formulation demonstrates its suitability as dry powder inhalation. It found to provide high and prolonged drug concentration within lungs after pulmonary administration in animal model.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Microspheres; Mucoadhesion; Pulmonary; Spray drying; Xyloglucan

Mesh:

Substances:

Year:  2013        PMID: 24507315     DOI: 10.1016/j.carbpol.2013.11.036

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  8 in total

Review 1.  Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2016-10-27

2.  Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability.

Authors:  Sung Hyun Im; Hoe Taek Jung; Myoung Jin Ho; Jeong Eun Lee; Hyung Tae Kim; Dong Yoon Kim; Hyo Chun Lee; Yong Seok Choi; Myung Joo Kang
Journal:  Pharmaceutics       Date:  2019-12-23       Impact factor: 6.321

Review 3.  The pulmonary route as a way to drug repositioning in COVID-19 therapy.

Authors:  Michelle Alvares Sarcinelli; Thalita Martins da Silva; Andressa Daniele Artico Silva; Beatriz Ferreira de Carvalho Patricio; Flávia Costa Mendes de Paiva; Raissa Santos de Lima; Manuela Leal da Silva; Helvécio Vinícius Antunes Rocha
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-24       Impact factor: 5.062

4.  Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis.

Authors:  Bhavya Vishwa; Afrasim Moin; D V Gowda; Syed M D Rizvi; Wael A H Hegazy; Amr S Abu Lila; El-Sayed Khafagy; Ahmed N Allam
Journal:  Pharmaceutics       Date:  2021-01-08       Impact factor: 6.321

5.  Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide.

Authors:  Sujit Kumar Debnath; Srinivasan Saisivam; Monalisha Debanth; Abdelwahab Omri
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

6.  New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy.

Authors:  Reham Waheed Hammad; Rania Abdel-Basset Sanad; Nevine Shawky Abdelmalak; Faisal A Torad; Randa Latif
Journal:  J Adv Res       Date:  2020-01-28       Impact factor: 10.479

Review 7.  PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.

Authors:  Yue Su; Bolun Zhang; Ruowei Sun; Wenfang Liu; Qubo Zhu; Xun Zhang; Rongrong Wang; Chuanpin Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

8.  Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: In vitro lung deposition and efficacy studies.

Authors:  Vishal Puri; Kabi Raj Chaudhary; Arti Singh; Charan Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.